Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Srikanth Vallurupalli

Concepts (296)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Coronary Artery Disease
12
2024
320
4.200
Why?
Atrial Fibrillation
5
2022
201
2.340
Why?
Percutaneous Coronary Intervention
9
2022
328
2.320
Why?
Ventricular Function, Right
6
2025
41
2.250
Why?
Ventricular Dysfunction, Right
3
2023
31
2.240
Why?
Echocardiography
13
2025
416
2.110
Why?
Aortic Valve Stenosis
5
2021
78
2.090
Why?
Stents
8
2022
372
1.960
Why?
Myocardial Infarction
6
2025
448
1.950
Why?
Angioplasty, Balloon, Coronary
4
2018
176
1.900
Why?
Echocardiography, Doppler
3
2025
56
1.520
Why?
Endocarditis
2
2022
31
1.310
Why?
Aortic Valve
3
2020
126
1.280
Why?
Thrombocytopenia
2
2022
92
1.260
Why?
Treatment Outcome
27
2025
5486
1.250
Why?
Electrocardiography
6
2024
281
1.200
Why?
Humans
71
2025
52593
1.200
Why?
Heart Failure
7
2025
587
1.170
Why?
Heart Ventricles
6
2025
269
1.130
Why?
Fractional Flow Reserve, Myocardial
4
2022
127
1.100
Why?
Ischemic Attack, Transient
2
2018
59
1.040
Why?
Anemia
2
2025
74
0.950
Why?
Veterans
2
2022
581
0.940
Why?
Pulmonary Artery
2
2025
147
0.920
Why?
Stroke
3
2021
515
0.910
Why?
Exercise Test
3
2024
144
0.840
Why?
Coronary Stenosis
2
2021
99
0.820
Why?
Risk Factors
17
2025
3952
0.820
Why?
Coronary Angiography
9
2022
388
0.800
Why?
Thrombosis
3
2024
262
0.770
Why?
Electric Countershock
1
2022
30
0.750
Why?
Endocarditis, Bacterial
1
2022
43
0.750
Why?
Atrial Appendage
1
2021
14
0.740
Why?
Kidney Diseases
3
2021
231
0.720
Why?
Catheter Ablation
2
2021
125
0.710
Why?
Retrospective Studies
16
2023
6671
0.710
Why?
Anticholesteremic Agents
1
2021
32
0.710
Why?
Hypercholesterolemia
1
2021
39
0.700
Why?
Cryosurgery
1
2021
36
0.680
Why?
Systole
4
2023
74
0.670
Why?
Male
34
2025
26863
0.670
Why?
Magnetic Resonance Imaging, Cine
3
2016
63
0.660
Why?
Operative Time
2
2017
77
0.660
Why?
Dyspnea
3
2018
80
0.640
Why?
Aged
22
2025
10191
0.640
Why?
Heart
2
2021
361
0.640
Why?
Digitalis
1
2019
5
0.640
Why?
Predictive Value of Tests
10
2022
952
0.640
Why?
Anticoagulants
3
2022
279
0.630
Why?
Middle Aged
24
2025
13096
0.610
Why?
Female
30
2025
28262
0.590
Why?
Cardiac Catheters
1
2018
12
0.580
Why?
Auscultation
1
2018
9
0.580
Why?
Heart Murmurs
1
2018
14
0.570
Why?
Asymptomatic Diseases
1
2018
38
0.570
Why?
Time Factors
9
2022
3000
0.550
Why?
Drug Prescriptions
1
2018
103
0.550
Why?
Coronary Disease
2
2015
165
0.540
Why?
Artifacts
1
2017
55
0.540
Why?
Heart Diseases
2
2017
226
0.540
Why?
Peripheral Arterial Disease
1
2018
77
0.540
Why?
Mediastinal Neoplasms
1
2017
18
0.530
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2018
149
0.520
Why?
Hospital Mortality
2
2018
459
0.520
Why?
Coronary Occlusion
1
2017
80
0.510
Why?
Surgical Procedures, Operative
1
2017
64
0.510
Why?
Absorbable Implants
1
2016
13
0.500
Why?
Tomography, Optical Coherence
1
2017
108
0.500
Why?
Pneumonia
1
2017
125
0.480
Why?
Acute Coronary Syndrome
1
2017
106
0.480
Why?
Respiratory Insufficiency
1
2017
117
0.480
Why?
Propafenone
1
2015
2
0.480
Why?
Tachycardia, Ectopic Atrial
1
2015
3
0.480
Why?
Flecainide
1
2015
4
0.480
Why?
Heart Conduction System
1
2015
25
0.470
Why?
Hypoparathyroidism
1
2015
5
0.470
Why?
Hypocalcemia
1
2015
13
0.470
Why?
Rhabdomyolysis
1
2015
12
0.470
Why?
Prognosis
6
2024
2118
0.460
Why?
Heart Rate
2
2021
319
0.460
Why?
Clinical Competence
1
2018
404
0.460
Why?
Thyroidectomy
1
2015
61
0.450
Why?
Cardiac Surgical Procedures
2
2017
328
0.440
Why?
Physician-Patient Relations
1
2015
144
0.430
Why?
Heart Neoplasms
1
2014
32
0.430
Why?
Fibroma
1
2014
40
0.430
Why?
Ventricular Function, Left
4
2019
177
0.420
Why?
Recurrence
4
2021
683
0.410
Why?
Theophylline
1
2013
18
0.410
Why?
Syncope
1
2013
31
0.400
Why?
Diabetes Mellitus, Type 2
4
2022
567
0.390
Why?
Physicians
1
2015
241
0.370
Why?
Heart Valve Prosthesis
2
2022
89
0.360
Why?
Heart Valve Prosthesis Implantation
2
2022
102
0.350
Why?
Stroke Volume
3
2025
160
0.350
Why?
Amyloidosis
3
2016
85
0.340
Why?
Octreotide
1
2010
9
0.330
Why?
Arkansas
6
2019
2029
0.330
Why?
Sulfonylurea Compounds
1
2010
6
0.330
Why?
Benzocaine
1
2009
4
0.320
Why?
Head and Neck Neoplasms
1
2013
287
0.320
Why?
Ventricular Remodeling
3
2021
65
0.320
Why?
Methemoglobinemia
1
2009
5
0.320
Why?
Hypoglycemia
1
2010
60
0.310
Why?
Echocardiography, Transesophageal
1
2009
61
0.310
Why?
Diagnosis, Differential
3
2018
1048
0.310
Why?
Anesthetics, Local
1
2009
79
0.300
Why?
Prospective Studies
3
2023
2457
0.290
Why?
Prosthesis Design
3
2022
261
0.280
Why?
Vasodilator Agents
2
2022
93
0.280
Why?
Reproducibility of Results
3
2025
1217
0.280
Why?
Myocardial Contraction
2
2019
112
0.280
Why?
Incidence
5
2019
1077
0.280
Why?
Coronary Vessels
2
2020
173
0.260
Why?
Chronic Disease
3
2018
588
0.260
Why?
Pressure
2
2017
103
0.250
Why?
Defibrillators, Implantable
2
2019
68
0.250
Why?
Ventricular Outflow Obstruction
1
2025
28
0.240
Why?
Randomized Controlled Trials as Topic
5
2022
600
0.230
Why?
Follow-Up Studies
5
2019
2291
0.230
Why?
Cardiomyopathies
2
2016
124
0.230
Why?
Foramen Ovale, Patent
2
2015
31
0.220
Why?
Cardiac Catheterization
3
2022
244
0.220
Why?
Myxoma
1
2024
18
0.220
Why?
Blood Transfusion
1
2025
129
0.220
Why?
Hepatitis C, Chronic
2
2015
86
0.220
Why?
Adult
9
2025
14170
0.200
Why?
Hospitalization
4
2022
749
0.200
Why?
Risk Assessment
4
2022
1350
0.190
Why?
Mitral Valve Insufficiency
1
2022
56
0.190
Why?
Bioprosthesis
1
2022
42
0.190
Why?
Electrodes
1
2022
35
0.190
Why?
Proportional Hazards Models
3
2020
444
0.190
Why?
Warfarin
1
2022
84
0.180
Why?
Pilot Projects
2
2022
721
0.180
Why?
Multiple Myeloma
4
2017
3050
0.180
Why?
Glycosides
1
2020
19
0.180
Why?
Sodium-Glucose Transporter 1
1
2020
6
0.180
Why?
Severity of Illness Index
2
2018
1037
0.180
Why?
Microscopy, Fluorescence, Multiphoton
1
2020
7
0.180
Why?
Vasodilation
1
2021
99
0.170
Why?
Tachycardia, Supraventricular
1
2021
37
0.170
Why?
Cardiovascular System
1
2020
55
0.170
Why?
United States
3
2022
5227
0.170
Why?
Calcinosis
1
2020
52
0.170
Why?
United States Department of Veterans Affairs
1
2022
293
0.170
Why?
Blood Pressure
1
2022
537
0.160
Why?
Digoxin
1
2019
29
0.160
Why?
Heart Failure, Systolic
1
2019
7
0.160
Why?
Electric Stimulation Therapy
1
2019
23
0.160
Why?
Inpatients
2
2018
209
0.150
Why?
Metoprolol
1
2019
13
0.150
Why?
Cardiotonic Agents
1
2019
85
0.150
Why?
Platelet Transfusion
1
2018
33
0.150
Why?
Kaplan-Meier Estimate
2
2017
485
0.150
Why?
Cerebrovascular Disorders
1
2018
45
0.150
Why?
Hepatitis C Antibodies
2
2015
19
0.140
Why?
Delivery of Health Care
1
2021
324
0.140
Why?
Databases, Factual
2
2018
715
0.140
Why?
Cardiac Imaging Techniques
1
2017
9
0.140
Why?
Cardiovascular Diseases
3
2020
495
0.140
Why?
Fever
1
2018
113
0.140
Why?
Renal Insufficiency, Chronic
1
2020
203
0.140
Why?
Logistic Models
2
2017
934
0.130
Why?
Hepacivirus
2
2015
106
0.130
Why?
Cell Transdifferentiation
1
2017
8
0.130
Why?
Xanthine Oxidase
1
2017
13
0.130
Why?
Foam Cells
1
2017
17
0.130
Why?
Hemorrhage
1
2018
224
0.130
Why?
Respiratory Sounds
1
2017
50
0.130
Why?
Survival Rate
2
2019
952
0.130
Why?
Cohort Studies
2
2018
1553
0.130
Why?
Myocytes, Smooth Muscle
1
2017
96
0.130
Why?
Radiographic Image Enhancement
1
2016
30
0.130
Why?
Gadolinium DTPA
1
2016
26
0.130
Why?
Chi-Square Distribution
1
2017
295
0.130
Why?
Propensity Score
1
2017
158
0.120
Why?
Inflammasomes
1
2017
67
0.120
Why?
Muscle, Smooth, Vascular
1
2017
136
0.120
Why?
Kidney
1
2020
723
0.120
Why?
Quality Improvement
1
2018
224
0.120
Why?
Magnetic Resonance Imaging
3
2024
1545
0.120
Why?
Voltage-Gated Sodium Channel Blockers
1
2015
5
0.120
Why?
Ventricular Function
1
2015
19
0.120
Why?
Intermittent Claudication
1
2015
16
0.120
Why?
Fundoplication
1
2015
20
0.120
Why?
Goiter
1
2015
4
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Immobilization
1
2015
15
0.120
Why?
Supine Position
1
2015
28
0.120
Why?
Pericardiectomy
1
2015
6
0.120
Why?
Healthcare Disparities
1
2018
300
0.120
Why?
Colchicine
1
2015
24
0.120
Why?
Length of Stay
1
2018
674
0.120
Why?
Pericarditis
1
2015
20
0.110
Why?
Aged, 80 and over
3
2018
3420
0.110
Why?
Mucolipidoses
1
2014
4
0.110
Why?
Scavenger Receptors, Class E
1
2017
204
0.110
Why?
Secondary Prevention
1
2015
85
0.110
Why?
Carcinoma, Renal Cell
1
2015
111
0.110
Why?
Thoracotomy
1
2014
33
0.110
Why?
Sulfonamides
1
2015
134
0.110
Why?
Obesity, Morbid
1
2015
89
0.110
Why?
Septal Occluder Device
1
2014
36
0.110
Why?
Pyrimidines
1
2015
200
0.110
Why?
Kidney Neoplasms
1
2015
181
0.100
Why?
Bone Marrow Transplantation
1
2014
113
0.100
Why?
Laparoscopy
1
2015
181
0.100
Why?
Mitral Valve
2
2022
57
0.100
Why?
Prosthesis Failure
2
2022
113
0.090
Why?
Administration, Oral
1
2013
455
0.090
Why?
Tomography, X-Ray Computed
1
2017
1162
0.090
Why?
Postoperative Complications
2
2015
1081
0.090
Why?
Injections, Subcutaneous
1
2010
51
0.080
Why?
Pericardium
1
2010
29
0.080
Why?
Gastrointestinal Agents
1
2010
41
0.080
Why?
Drug Monitoring
1
2010
83
0.080
Why?
Quality of Life
1
2015
882
0.080
Why?
Cause of Death
2
2020
161
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1031
0.080
Why?
Lipid Metabolism
1
2010
188
0.080
Why?
Renal Dialysis
1
2010
191
0.070
Why?
Kidney Failure, Chronic
1
2010
216
0.070
Why?
Dose-Response Relationship, Drug
1
2010
1378
0.060
Why?
Exercise
1
2010
548
0.060
Why?
Blood Flow Velocity
1
2025
95
0.060
Why?
Oxidative Stress
1
2010
810
0.060
Why?
Disease Progression
2
2020
873
0.060
Why?
RNA, Viral
2
2015
125
0.060
Why?
Gadolinium
1
2024
44
0.050
Why?
Heart Atria
1
2024
64
0.050
Why?
Sensitivity and Specificity
1
2025
883
0.050
Why?
Contrast Media
1
2024
175
0.050
Why?
Vitamin K
1
2022
17
0.050
Why?
American Heart Association
1
2022
33
0.050
Why?
Telemetry
1
2021
30
0.040
Why?
Tachycardia
1
2021
28
0.040
Why?
Acute Disease
1
2022
387
0.040
Why?
Glucosides
1
2020
24
0.040
Why?
Diabetic Ketoacidosis
1
2020
17
0.040
Why?
Platelet Aggregation Inhibitors
1
2022
213
0.040
Why?
Glomerular Filtration Rate
1
2020
130
0.040
Why?
Early Diagnosis
1
2020
87
0.040
Why?
Benzhydryl Compounds
1
2020
69
0.040
Why?
Exercise Tolerance
1
2019
48
0.040
Why?
Death, Sudden, Cardiac
1
2019
60
0.040
Why?
Anti-Arrhythmia Agents
1
2019
81
0.040
Why?
Recovery of Function
1
2019
202
0.040
Why?
Oxygen Consumption
1
2019
200
0.040
Why?
Adrenergic beta-Antagonists
1
2019
112
0.040
Why?
Feasibility Studies
1
2020
403
0.040
Why?
Uric Acid
1
2017
25
0.030
Why?
Scavenger Receptors, Class A
1
2017
39
0.030
Why?
Referral and Consultation
1
2018
292
0.030
Why?
RNA Interference
1
2017
186
0.030
Why?
Registries
1
2020
629
0.030
Why?
Transfection
1
2017
369
0.030
Why?
Biopsy, Needle
1
2016
182
0.030
Why?
Hernia, Hiatal
1
2015
9
0.030
Why?
ROC Curve
1
2016
254
0.030
Why?
Disease Models, Animal
1
2020
1486
0.030
Why?
Mice, Inbred C57BL
1
2020
1900
0.030
Why?
Patient Acceptance of Health Care
1
2018
358
0.030
Why?
Gastroesophageal Reflux
1
2015
48
0.030
Why?
Tubulin Modulators
1
2015
28
0.030
Why?
Indazoles
1
2015
47
0.030
Why?
Seroepidemiologic Studies
1
2014
44
0.030
Why?
Reactive Oxygen Species
1
2017
422
0.030
Why?
Multivariate Analysis
1
2016
602
0.030
Why?
Biopsy
1
2016
607
0.030
Why?
Survival Analysis
1
2016
673
0.030
Why?
Pneumonectomy
1
2014
29
0.030
Why?
Angiogenesis Inhibitors
1
2015
184
0.030
Why?
Prosthesis Implantation
1
2014
49
0.030
Why?
Posture
1
2014
65
0.030
Why?
Anti-Inflammatory Agents
1
2015
166
0.030
Why?
Myocardium
1
2016
479
0.030
Why?
Polymerase Chain Reaction
1
2014
460
0.030
Why?
Age Distribution
1
2013
175
0.030
Why?
Immunohistochemistry
1
2016
984
0.030
Why?
Syndrome
1
2014
253
0.030
Why?
Cell Line, Tumor
1
2017
1436
0.020
Why?
Ventricular Dysfunction, Left
1
2014
108
0.020
Why?
Transplantation, Autologous
1
2014
488
0.020
Why?
Comorbidity
1
2013
631
0.020
Why?
Oxygen
1
2014
336
0.020
Why?
alpha-2-HS-Glycoprotein
1
2010
2
0.020
Why?
Thiobarbituric Acid Reactive Substances
1
2010
11
0.020
Why?
Signal Transduction
1
2017
1714
0.020
Why?
Blood Proteins
1
2010
84
0.020
Why?
C-Reactive Protein
1
2010
152
0.020
Why?
Interleukin-6
1
2010
277
0.020
Why?
Lung Neoplasms
1
2014
634
0.020
Why?
Animals
1
2020
13507
0.010
Why?
Young Adult
1
2013
4337
0.010
Why?
Adolescent
1
2013
6737
0.010
Why?
Vallurupalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description